Cystatin C Assay Market in terms of revenue was estimated to be worth $377 million in 2023 and is poised to reach $540 million by 2028, growing at a CAGR of 7.5% from 2023 to 2028 according to a new report by MarketsandMarkets™. The growth of this market is majorly driven by growing number of old age population and rising number of kidney diseases. However, high development costs of cystatin C assay may challenge the growth of this market.
Download an Illustrative overview:
The Cystitis C test industry is balanced for critical development within the close future, driven by a rising request for exact and dependable biomarkers in healthcare. Cystitis C, a promising marker of kidney work, is picking up noticeable quality as an elective to conventional creatinine-based estimations. With a maturing populace, the expanding predominance of incessant kidney infections, and a developing accentuation on early illness discovery, the Cystitis C measure industry is anticipated to grow quickly.
Browse in-depth TOC on "Cystatin C Assay Market"
215 - Tables
42 - Figures
271 – Pages
Key Market Players of Cystatin C Assay Industry:
The significant players in the cystatin C assay are Siemens Healthcare GmbH (Germany), Thermo Fisher Scientific Inc. (US), Abbott (US), Roche Diagnostics Limited. (Switzerland), and Bio-Techne (US), Randox Laboratories Ltd. (UK), DiaSys Diagnostic Systems GmbH (Germany), and Eurolyser Diagnostica GmbH (Austria)
Cystatin C Assay Market Dynamics:
Drivers:
· Rising prevalence of kidney diseases
· Growing geriatric population
· Recent advancements in chemiluminescence immunoassay technologies
· Growth in biotechnology and biopharmaceutical industries
· Increasing adoption of POC testing
· Supportive government policies
Restraints:
· Stringent requirements for approval of cystatin C assay instruments and consumables
· High development costs of cystatin C assays
Opportunities:
· Growth opportunities in emerging economies
· Importance of companion diagnostics
· Development of condition-specific biomarkers and tests
Challenge:
· Dearth of skilled professionals
Segmentation by product and service
· Analyzers
· Kits
· Reagents
Segmentation by application
· Diagnostics
· Research
Segmentation by end user
· Hospitals
· Clinical Laboratories
· Pharmaceutical and Biotechnology Companies & CROs & Academic research institutes
Regional segmentation
· North America holds largest share
· Asia Pacific fastest growing region
· Europe second largest segment
· Latin America and Middle East & Africa emerging markets
Regional market breakdown
· North America largest share due to high healthcare spending, developed infrastructure
· Asia Pacific fastest growth from increasing healthcare access and aging populations
· Europe also major market but growing at slower pace than APAC
· Latin America and Middle East & Africa smaller markets but seeing growth
Content Source:
https://www.marketsandmarkets.com/PressReleases/cystatin-c-assay.asp
https://www.marketsandmarkets.com/ResearchInsight/cystatin-c-assay-market.asp
About MarketsandMarkets™:
MarketsandMarkets™ has been recognized as one of America's best management consulting firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.
Earlier this year, we made a formal transformation into one of America's best management consulting firms as per a survey conducted by Forbes.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.
Comments
0 comment